Premium
Imbalance of helper and suppressor T lymphocytes in malignant non‐hodgkin lymphomas: An In situ morphometric analysis
Author(s) -
Gattringer C.,
Huber H.,
Radaszkiewicz T.,
Pfaller W.,
Braunsteiner H.
Publication year - 1984
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910330607
Subject(s) - malignancy , pathology , lymphoma , lymphatic system , biology , in situ , t cell , medicine , immunology , chemistry , immune system , organic chemistry
The number and distribution of reactive T cells within 100 malignant B‐cell lymphomas were evaluated in situ by immunomorphometry using stereological methods. Findings were related to histological and clinical parameters. A mean of 2 × 10 4 reactive T cells/μI tumour tissue was found. This corresponds to 40% of the T‐cell content of normal lymphatic tissues. The distribution of reactive T cells within the tumours was diffuse except for centroblastic/centrocytic lymphomas. When evaluating the different histological entities a correlation between number of helper T cells, T helper:T suppressor (T H :T S ) ratio and histological subgroups emerged, particularly in non‐Hodgkinlymphomas of low‐grade malignancy. The highest ratio was found in prognostically favourable subgroups, CLL(2.7 ± 0.3) and tumour areas of centroblastic/centrocytic lymphomas (2.9 ± 0.4). In contrast, a significantly lower ratio was found in centrocytic lymphomas (1.4 ± 0.3) corresponding well to the worst prognosis of this subgroup. The relationship between the number of helper T cells in tumour tissues, T H :T S ratio and prognosis was confirmed and extended by the evaluation of clinical data. It could be shown that, independently of histological criteria, a close correlation exists between the number of T cells, particularly T helper cells within the tumour, T H :T S ratio and clinical course. Patients with a favourable course had 1.4 × 10 4 T helper cells/μI tumour tissue compared to only 0.8 × 10 4 for patients with an unfavourable clinical course (p<0.01); the T H :T S ratio was 2.8 for the favourable and 1.8 for the unfavourable group, respectively (p<0.04). In contrast, neither treatment nor tumour stage had a clear‐cut influence on the extent of T‐cell infiltration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom